Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines
- 14 January 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (2) , 533-541
- https://doi.org/10.1038/sj.onc.1202317
Abstract
We have compared the DNase I hypersensitivity of the regulatory region of two estrogen-regulated genes, pS2 and cathepsin D in hormone-dependent and -independent breast carcinoma cell lines. This strategy allowed the identification of two important control regions, one in pS2 and the other in cathepsin D genes. In the hormone-dependent MCF7 cell line, within the pS2 gene 5′-flanking region, we detected two major DNase I hypersensitive sites, induced by estrogens and/or IGFI: pS2-HS1, located in the proximal promoter and pS2-HS4, located −10.5 Kb from the CAP site, within a region that has not been cloned. The presence of these two DNase I hypersensitive sites correlates with pS2 expression. Interestingly in MCF7 cells, estrogens and IGFI induced indistinguishable chromatin structural changes over the pS2 regulatory region, suggesting that the two transduction-pathways converge to a unique chromatin target. In two cell lines that do not express pS2, MDA MB 231, a hormone-independent cell line that lacks the estrogen receptor α, and HE5, a cell line derived from MDA MB 231 by transfection that expresses estrogen receptor α, there was only one hormone-independent DNase I hypersensitive site. This site, pS2-HS2, was located immediately upstream of pS2-HS1. In MCF7 cells, two major DNase I hypersensitive sites were present in the 5′-flanking sequences of the cathepsin D gene, which is regulated by estrogens in these cells. These sites, catD-HS2 and catD-HS3, located at positions −2.3 Kb and −3.45 Kb, respectively, were both hormone-independent. A much weaker site, catD-HS1, covered the proximal promoter. In MDA MB 231 cells, that express cathepsin D constitutively, we detected an additional strong hormone-independent DNase I hypersensitive site, catD-HS4, located at position −4.3 Kb. This region might control the constitutive over-expression of cathepsin D in hormone-independent breast cancer cells. All together, these data demonstrate that a local reorganization of the chromatin structure over pS2 and cathepsin D promoters accompanies the establishment of the hormone-independent phenotype of the cells.Keywords
This publication has 33 references indexed in Scilit:
- Identification of a Motif within the 5‘ Regulatory Region of pS2 Which Is Responsible for AP-1 Binding and TCDD-Mediated SuppressionBiochemistry, 1997
- The CBP co-activator is a histone acetyltransferaseNature, 1996
- Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein KinaseScience, 1995
- Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.Proceedings of the National Academy of Sciences, 1993
- Progestin-induced fatty acid synthetase in human mammary tumors: From molecular to clinical studiesThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Cathepsin D in breast cancerBreast Cancer Research and Treatment, 1990
- Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.Proceedings of the National Academy of Sciences, 1989
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogensBiochemical and Biophysical Research Communications, 1987